Latham, Davis Polk Guide Psychedelic Co.'s SPAC Merger
Special purpose acquisition company Silver Spike Acquisition Corp. II announced Thursday it had entered into an agreement with psychedelic pharmaceutical developer Eleusis to take the clinical-stage life sciences company public, in...To view the full article, register now.
Already a subscriber? Click here to view full article